+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Selecta Biosciences - logo

Selecta Biosciences was founded in 2007 and is headquartered in Watertown, Massachusetts. It is a biopharmaceutical company, they create biological therapies that fight against unwanted immune responses. Selecta Biosciences specialise in Synthetic Vaccine Particles (SVP™) technology platform. They use this treatment to fight rare and serious diseases. Selectas current pipeline includes: SVP- enabled enzyme, oncology and gene therapies.

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 700 Pages
  • Global
From
Crigler-Najjar Syndrome (Genitourinary Disorders) - Drugs In Development, 2021 - Product Thumbnail Image

Crigler-Najjar Syndrome (Genitourinary Disorders) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 41 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 500 Pages +
  • Global
From
Cell and Gene Therapy CRO Market: Distribution by Area of Expertise, Scale of Operation, Therapeutic Area, and Geography: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Cell and Gene Therapy CRO Market: Distribution by Area of Expertise, Scale of Operation, Therapeutic Area, and Geography: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • September 2022
  • 330 Pages
  • Global
From
Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030 - Product Thumbnail Image

Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

  • Report
  • October 2019
  • 302 Pages
  • Global
From
Prefilled Syringe Fill / Finish Services Market, 2020-2030 - Product Thumbnail Image

Prefilled Syringe Fill / Finish Services Market, 2020-2030

  • Report
  • February 2020
  • 267 Pages
  • Global
From
Peanut Allergy - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Peanut Allergy - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Primary Sclerosing Cholangitis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Primary Sclerosing Cholangitis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 99 Pages
  • Global
From
Ornithine Transcarbamylase Deficiency Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Ornithine Transcarbamylase Deficiency Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 92 Pages
  • Global
From
Pompe Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Pompe Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines - Product Thumbnail Image

Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines

  • Report
  • May 2021
  • 62 Pages
  • Global
From
Hyperuricemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Hyperuricemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 86 Pages
  • Global
From
Crigler-Najjar Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Crigler-Najjar Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 39 Pages
  • Global
From
Selecta Biosciences (SELB:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Selecta Biosciences (SELB:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • December 2023
  • 89 Pages
From
Comprehensive Report on Selecta Biosciences Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Selecta Biosciences Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator